WBR0120
| Author | [[PageAuthor::William J Gibson (Reviewed by Yazan Daaboul, M.D. and Rim Halaby, M.D. [1])]] |
|---|---|
| Exam Type | ExamType::USMLE Step 1 |
| Main Category | MainCategory::Genetics |
| Sub Category | SubCategory::Cardiology |
| Prompt | [[Prompt::An 22-year-old man collapses while playing during a basketball game. Despite appropriate cardiopulmonary resuscitation efforts, the patient is finally pronounced dead. At autopsy, toxicological tests are negative for alcohol or illicit drugs. The pathologist further notes a large, thick myocardium with disarrayed muscle fibers. He concludes that the patient most probably died of an arrhythmia. Mutation in gene encoding which of the following proteins most likely caused the patient's condition?]] |
| Answer A | AnswerA::Beta-myosin |
| Answer A Explanation | [[AnswerAExp::Hypertrophic obstructive cardiomyopathy (HOCM) is caused by a mutation of sarcomere proteins, such as beta-myosin.]] |
| Answer B | AnswerB::Potassium ion channel |
| Answer B Explanation | [[AnswerBExp::Long QT syndromes, such as LQT1 and LQT2, are caused by potassium channel gene mutations KCNQ1 and KCNE2, respectively. Also, Jervell and Lange-Nielsen (JLN) syndrome is a rare but clinically significant long QT syndrome that involve potassium channel mutations.]] |
| Answer C | AnswerC::Calcium ion channel |
| Answer C Explanation | [[AnswerCExp::Among patients with intolerance to beta-blocker, patients with HOCM can be treated with a calcium channel blocker, such as verapamil, to decrease myocardial contractility. Calcium ion channel mutations are associated with neurological diseases.]] |
| Answer D | AnswerD::Ryanodine receptor |
| Answer D Explanation | AnswerDExp::Mutation of the ryanodine receptor is associted with malignant hyperthermia (MH). The ryanodine receptor ''RYR1'' gene encodes calcium release in skeletal muscles. Patients with a mutated ''RYR1'' are susceptible to MH. |
| Answer E | AnswerE::Myostatin |
| Answer E Explanation | [[AnswerEExp::Mutations of myostatin are extremely rare and cause widespread, gross muscle hypertrophy and increase in muscle mass.]] |
| Right Answer | RightAnswer::A |
| Explanation | [[Explanation::Hypertrophic Obstructive Cardiomyopathy (HOCM) is an autosomal dominant genetic disorder. It is caused by a missense mutation in 1 of at least 14 genes that encode cardiac sarcomeres. Most common mutations encode beta-myosin heavy chain (MYH7) and cardiac myosin binding protein C (MYBPC3). HOCM is characterized by a hypertrophic cardiomyopathy that involves the ventricular septum resulting in dynamic left ventricular outflow tract obstruction, mitral regurgitation, and diastolic dysfunction. Patients usually lead a normal life, while some experience symptoms of myocardial ischemia such as angina and dyspnea. A minority of patients suffer ventricular arrhythmias and die at young age.
HOCM may be diagnosed incidentally during routine physical examination or work-up. The most important findings on physical examination suggestive of HOCM is a systolic ejection murmur that increases in intensity during maneuvers the decrease preload, such as standing from a squatting position. ECG findings include evidence of left ventricular hypertrophy. The definitive diagnosis of HOCM is made by 2-D echocardiography, which demonstrates asymmetric hypertrophy of the myocardium with a septal thickness greater than the thickness of the free well, and continuous-wave Doppler echocardiography, which reveals resting obstruction. Management of patients with HOCM includes symptomatic relief using beta-blockers. Other prophylactic measures include infective endocarditis prophylaxis, avoidance of high intensity exercise or dehydration, genetic counseling, and period screening for other immediate family members. Surgical intervention by septal myomectomy is rarely required. Mosher DS, Quignon P, Bustamante CD, et al. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygous dogs. PLoS Genet. 2007;3(5):e79 Nader A, Massumi A, Cheng J, et al. Inherited arrhythmic disorders: long QT and Brugada syndromes. Tex Heart Inst J. 2007;34(1):67-75 Nishimura RA, Holmes DR. Hypertrophic obstructive cardiomyopathy. N Engl J Med. 2004;350:1320-7 Roncarati R, Latronico MV, Musumeci B, et al. Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy. J Cell Physiol. 2011;226(11):2894-900. First Aid 2014 page 290]] |
| Approved | Approved::Yes |
| Keyword | WBRKeyword::HOCM, WBRKeyword::Hypertrophic cardiomyopathy, WBRKeyword::HCM, WBRKeyword::Genetics, WBRKeyword::Sudden death, WBRKeyword::Beta-myosin, WBRKeyword::Beta, WBRKeyword::Myosin, WBRKeyword::Beta myosin, WBRKeyword::Hypertrophic obstructive cardiomyopathy, WBRKeyword::Sudden, WBRKeyword::Death, WBRKeyword::Sudden death, WBRKeyword::Autopsy, WBRKeyword::Mutation, WBRKeyword::Autosomal, WBRKeyword::Dominant, WBRKeyword::Autosomal dominant |
| Linked Question | Linked:: |
| Order in Linked Questions | LinkedOrder:: |